āĻšā§āĻŽQGEN âĸ NYSE
add
Qiagen NV
ā§Ēā§¨.ā§Ģā§Ž$
ā§Ž āĻŽā§, ā§§:ā§¨ā§Ŧ:ā§§ā§Ž PM GMT -ā§Ē · USD · NYSE · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻāĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ āĻ¯ā§āĻā§āĻ¤āĻ°āĻžāĻˇā§āĻā§āĻ°-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋNL-āĻ āĻšā§āĻĄāĻā§ā§āĻžāĻ°ā§āĻāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§Ēā§¨.ā§Ŧā§¨$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§Ēā§¨.ā§Ļā§Ģ$ - ā§Ēā§Š.ā§Ļā§Ģ$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§Šā§.ā§Ŧā§Š$ - ā§Ēā§¯.ā§Šā§Ļ$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§¯ā§§ā§¯.ā§ā§¯Â āĻā§ USD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§§ā§Ē.ā§Ģā§Ģ āĻ˛āĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
ā§§ā§§ā§§.ā§¨ā§Ž
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
ā§Ļ.ā§Ģā§¯%
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
NYSE
āĻāĻŦāĻ°ā§ āĻ°ā§ā§āĻā§
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (USD) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Ģā§¨.ā§§ā§¨Â āĻā§ | ā§¨.ā§Šā§Ŧ% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§¨ā§Ļ.ā§Ģā§Ŧ āĻā§ | -ā§¨.ā§Šā§Ž% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Ž.ā§Žā§ŠÂ āĻā§ | -ā§¯.ā§Ģā§% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | ā§§ā§Ŧ.ā§¯ā§Ģ | -ā§§ā§§.ā§Ŧā§Š% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Ļ.ā§Ŧā§§ | ā§.ā§Žā§Š% |
EBITDA | ā§§ā§.ā§ā§Ļ āĻā§ | ā§¯.ā§ā§§% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§¨ā§¯.ā§Žā§¨% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§§ā§§ā§Ģ.ā§Šā§Ļ āĻā§ | ā§¯.ā§Ļā§Ļ% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§Ģā§Ŧā§Ž.ā§¯ā§Ŧ āĻā§ | -ā§Ŧ.ā§¯ā§Ŧ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§¨ā§§ā§¨.ā§¨ā§ŠÂ āĻā§ | -ā§Ž.ā§Ļā§¨% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Šā§Ģā§Ŧ.ā§ā§ŠÂ āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§¨ā§§.ā§Ŧā§§Â āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§¨.ā§Ģā§Ž | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§Ŧ.ā§Ļā§Ē% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | ā§Ŧ.ā§Žā§Ļ% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (USD) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Ž.ā§Žā§ŠÂ āĻā§ | -ā§¯.ā§Ģā§% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§§ā§¯.ā§§ā§Ģ āĻā§ | ā§¨ā§Ŧ.ā§Ģā§¨% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§Ŧā§.ā§Žā§Ģ āĻ˛āĻž | ā§Žā§Ž.ā§Šā§¯% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§Ēā§Ž.ā§¯ā§Ļ āĻā§ | -ā§Ŧ,ā§Ēā§ā§Ģ.ā§ā§¯% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | -ā§Šā§Ļ.ā§¯ā§Ē āĻā§ | -ā§Ēā§Ģā§§.ā§Ļā§Š% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | ā§¨ā§Ē.ā§Ģā§Ģ āĻā§ | ā§§,ā§¯ā§Ēā§Š.ā§Ŧā§Š% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in respectively Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§¨ā§¯ āĻ¨āĻā§, ā§§ā§¯ā§Žā§Ē
āĻ¸āĻĻāĻ° āĻĻāĻĒā§āĻ¤āĻ°
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§Ģ,ā§¨ā§Šā§¨
